AMGN - Obesity drugs to expand U.S. GDP by 1% in the coming years: Goldman Sachs
2024-02-22 14:41:34 ET
More on Amgen, Eli Lilly, etc.
- Pfizer's Post-Pandemic Pivot
- Pfizer: Turnaround Is Gaining Momentum
- Eli Lilly: Yes, It Is Too Late To Join The Party
- Novo to face Wegovy competition in India as local versions loom: Reuters
- Weight-loss drugs cut grocery bills by up to 9% - Morgan Stanley